Cc. Connolly et al., COUNTERREGULATION BY EPINEPHRINE AND GLUCAGON DURING INSULIN-INDUCED HYPOGLYCEMIA IN THE CONSCIOUS DOG, Diabetes research and clinical practice, 31(1-3), 1996, pp. 45-56
We assessed the combined role of epinephrine and glucagon in regulatin
g gluconeogenic precursor metabolism during insulin-induced hypoglycem
ia in the overnight-fasted, adrenalectomized, conscious dog. In paired
studies (n = 5) insulin was infused intraportally al 5 mU . kg(-1) .
min(-1) for 3 h. Epinephrine was infused at a basal rate (B-EPI) or va
riable rate to simulate the normal epinephrine response to hypoglycemi
a (H-EPI), whereas in both groups the hypoglycemia-induced rise in cor
tisol was simulated by cortisol infusion. Plasma glucose fell to simil
ar to 42 mg/dl in both groups. Glucagon failed to rise in B-EPI, but i
ncreased normally in H-EPI. Hepatic glucose release fell in B-EPI but
increased in H-EPI. In B-EPI, the normal rise in lactate levels and ne
t hepatic lactate uptake was prevented. Alanine and glycerol metabolis
m were similar in both groups. Since glucagon plays little role in reg
ulating gluconeogenic precursor metabolism during 3 h of insulin-induc
ed hypoglycemia, epinephrine must be responsible for increasing lactat
e release from muscle, but is minimally involved in the lipolytic resp
onse. In conclusion, a normal rise in epinephrine appears to be requir
ed to elicit an increase in glucagon during insulin-induced hypoglycem
ia in the dog. During insulin-induced hypoglycemia, epinephrine plays
a major role in maintaining an elevated rate of glucose production, pr
obably via muscle lactate release and hepatic lactate uptake.